CVD Risk and Outcome Heterogeneity in Older Adults with Diabetes
老年糖尿病患者的 CVD 风险和结果异质性
基本信息
- 批准号:9382446
- 负责人:
- 金额:$ 33.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectAgeAge of OnsetAged, 80 and overAgingAmericanBiological MarkersBirthBlood PressureCardiovascular DiseasesCaringClinicalClinical ManagementComorbidityComplexComplicationCross-Sectional StudiesCystatinsDataData AnalysesDevelopmentDiabetes MellitusDrug PrescriptionsElderlyEnrollmentEthnic OriginEthnic groupEventGlycosylated hemoglobin AGoalsGuidelinesHealthHealth StatusHeterogeneityHigh Density Lipoprotein CholesterolIndividualInterviewLinkMedicalMedicareMedicare claimMethodsModelingMorbidity - disease rateOutcomeParticipantPathway interactionsPatientsPharmaceutical PreparationsPhysical assessmentPhysiciansPhysiologicalPopulationPrediabetes syndromeProcessResearchResearch PersonnelRespondentRetirementRiskRisk FactorsRisk stratificationRoleSpecific qualifier valueStatistical Data InterpretationStudy modelsSurveysTechniquesTestingTimeTranslatingWeightWorkage relatedagedbasecardiovascular disorder riskclinical decision-makingclinically relevantcohortdisabilitydisorder riskexperiencefollow-upfrailtyhealth dataindividualized medicineinnovationinsightlongitudinal analysismultiple chronic conditionsnovelolder patientpersonalized carepersonalized managementpopulation basedpost gamma-globulinsprognosticprognostic toolsextoolwaist circumferencewalking speed
项目摘要
Project Summary
The overall goal of the proposed research is to provide evidence for individualizing care for older adults with
prediabetes (PD) and diabetes (DM) by investigating their risks and development of CVD and disability.
Older adults with PD and DM suffer disproportionality from diabetes morbidity, particularly CVD and also
disability, an outcome that really matters to patients. Our study will use longitudinal data to observe CVD and
disability development in PD/DM patients over time. These analyses will lead to practical population based
methods to stratify people with DM for their individual risks of CVD and disability, helping to individualize care.
Our research will test whether CVD and disability development in PD/DM follows several distinct trajectories
with different predictors and risks that will differ by age. We hypothesize that CVD explains the risk of
disability more in people with PD/DM < 75 than in those older, and that we can develop risk models to better
guide clinical decision-making. The specific aims are to: 1), investigate heterogeneity in the risk of developing
CVD In adults from middle to old age aging with PD/DM; 2) investigate heterogeneity in their risk of developing
disability; and 3) specify risk models for CVD and disability in people aging with PD/DM, including people with
diverse ethnicities and the oldest old.
To accomplish our goal we will perform secondary data analysis of the Health and Retirement Survey (HRS) a
nationally representative health interview survey that has been collecting data for over 20 years. Besides
extensive health interview information, the HRS also features biomarkers (HBA1c, total and HDL cholesterol,
CRP, cystatin), physical assessment information (blood pressure, weight, waist circumference, walking speed),
prescription medications for a subsample of participants, and Medicare claims linkages. The HRS allows us to
evaluate key variables longitudinally, to account for ethnicity and cohort changes in people aging with PD/DM,
and to consider management and its changes over many years. The HRS has enrolled nearly 6,000 people with
diabetes aged 51 to over 100. We will employ sophisticated statistical analyses as important tools to test our
ideas about dynamic processes, time-dependent risks and age-cohort differences. We believe this work will
provide evidence to guide individualized DM care for older patients and will will lead to risk models for
outcomes that include people of advanced age, diverse ethnicities and complex health status.
项目摘要
拟议研究的总体目标是为老年人的个性化护理提供证据,
糖尿病前期(PD)和糖尿病(DM),通过调查他们的风险和心血管疾病和残疾的发展。
患有PD和DM的老年人患有糖尿病发病率,特别是CVD,
残疾,这对病人来说是很重要的我们的研究将使用纵向数据来观察CVD,
PD/DM患者随时间的残疾发展。这些分析将导致基于人口的实际
根据糖尿病患者心血管疾病和残疾的个体风险对他们进行分层的方法,有助于个性化护理。
我们的研究将测试PD/DM患者的CVD和残疾发展是否遵循几个不同的轨迹
不同的预测因素和风险会因年龄而异。我们假设心血管疾病可以解释
PD/DM < 75的患者比老年人残疾更多,我们可以开发风险模型,
指导临床决策。具体目标是:1)研究发展风险的异质性
CVD在中老年PD/DM患者中; 2)研究他们发生CVD风险的异质性,
残疾;和3)指定患有PD/DM的老年人中CVD和残疾的风险模型,
不同的种族和最老的老人。
为了实现我们的目标,我们将对健康和退休调查(HRS)a进行二级数据分析。
全国代表性的健康访谈调查已经收集了20多年的数据。除了
广泛的健康访谈信息,HRS还具有生物标志物(HBA 1c,总胆固醇和HDL胆固醇,
CRP、胱抑素)、身体评估信息(血压、体重、腰围、步行速度),
参与者子样本的处方药和医疗保险索赔联系。HRS允许我们
纵向评价关键变量,以解释PD/DM老年人的种族和队列变化,
并考虑多年来的管理及其变化。HRS已经招募了近6,000人,
51岁至100岁的糖尿病患者。我们会采用先进的统计分析作为重要工具,以测试我们的
关于动态过程、时间依赖性风险和年龄组差异的想法。我们相信这项工作将
为老年患者提供指导个体化DM护理的证据,并将导致以下风险模型:
结果包括老年人,不同种族和复杂的健康状况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Caroline S Blaum其他文献
Caroline S Blaum的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Caroline S Blaum', 18)}}的其他基金
Enhanced Quality in Primary Care for Elders with Diabetes and Dementia (EQUIPED-ADRD)
提高患有糖尿病和痴呆症的老年人的初级保健质量 (EQUIPED-ADRD)
- 批准号:
9412643 - 财政年份:2017
- 资助金额:
$ 33.81万 - 项目类别:
CVD Risk and Outcome Heterogeneity in Older Adults with Diabetes
老年糖尿病患者的 CVD 风险和结果异质性
- 批准号:
10163647 - 财政年份:2017
- 资助金额:
$ 33.81万 - 项目类别:
Summer Research Training in Aging for Medical Students
医学生夏季衰老研究培训
- 批准号:
8960119 - 财政年份:2015
- 资助金额:
$ 33.81万 - 项目类别:
Summer Research Training in Aging for Medical Students
医学生夏季衰老研究培训
- 批准号:
9087083 - 财政年份:2015
- 资助金额:
$ 33.81万 - 项目类别:
Clinical Database to Support Comparative Effectiveness Studies of Complex Patient
支持复杂患者比较疗效研究的临床数据库
- 批准号:
8015802 - 财政年份:2010
- 资助金额:
$ 33.81万 - 项目类别:
Outcomes of Blood Pressure Management in Diabetes Patients with Comorbidities
合并症糖尿病患者血压管理的结果
- 批准号:
7682869 - 财政年份:2008
- 资助金额:
$ 33.81万 - 项目类别:
Outcomes of Blood Pressure Management in Diabetes Patients with Comorbidities
合并症糖尿病患者血压管理的结果
- 批准号:
7534625 - 财政年份:2008
- 资助金额:
$ 33.81万 - 项目类别:
AEROBIC PERFORMANCE, MOBILITY LIMITATIONS & EXERCISE IN OLDER ADULTS W/ DIABETES
有氧运动表现、活动能力限制
- 批准号:
7603794 - 财政年份:2007
- 资助金额:
$ 33.81万 - 项目类别:
AEROBIC FUNCTIONING AND MOBILITY PERFORMANCE IN OVERWEIGHT AND OBESE ADULTS
超重和肥胖成年人的有氧功能和活动能力
- 批准号:
7603795 - 财政年份:2007
- 资助金额:
$ 33.81万 - 项目类别:
AEROBIC FUNCTIONING AND MOBILITY PERFORMANCE IN OVERWEIGHT AND OBESE ADULTS
超重和肥胖成年人的有氧功能和活动能力
- 批准号:
7376631 - 财政年份:2006
- 资助金额:
$ 33.81万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 33.81万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 33.81万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 33.81万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 33.81万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 33.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 33.81万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 33.81万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 33.81万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 33.81万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 33.81万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




